Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines.

about

Small molecule inhibitors for acute myeloid leukemia: where is the field heading?Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML.

P2860

Q38644520-8145226A-949D-4CF4-99BA-D96E3970FFFB Q41815540-E915550C-FCC7-4C9A-B814-D3D023E6D17E

P2860

Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines.

Item

http://www.wikidata.org/entity/Q41872280

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Selective AKR1C3 Inhibitors Po ...... oid Leukemia (AML) Cell Lines.

@en

type

Item

label

Selective AKR1C3 Inhibitors Po ...... oid Leukemia (AML) Cell Lines.

@en

prefLabel

Selective AKR1C3 Inhibitors Po ...... oid Leukemia (AML) Cell Lines.

@en

P1476

Selective AKR1C3 Inhibitors Po ...... oid Leukemia (AML) Cell Lines.

@en

P2093

Nehal Gupta

http://www.w3.org/2001/XMLSchema#string

Paul C Trippier

http://www.w3.org/2001/XMLSchema#string

Tianzhu Zang

http://www.w3.org/2001/XMLSchema#string

Trevor M Penning

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity

Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells

Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

The NCI60 human tumour cell line anticancer drug screen

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Drug combination studies and their synergy quantification using the Chou-Talalay method

The heck reaction as a sharpening stone of palladium catalysis.

P304

774-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.6B00163

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kshitij Verma

P577

2016-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27563402

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4983729

http://www.w3.org/2001/XMLSchema#string

Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines.

about

P2860

P2860

Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932